ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CTEC Convatec Group Plc

285.00
-1.60 (-0.56%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.60 -0.56% 285.00 284.20 284.60 288.80 283.80 285.60 4,854,979 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 44.75 5.83B

ConvaTec Group PLC Director/PDMR Shareholding (7472O)

21/05/2018 1:02pm

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 7472O

ConvaTec Group PLC

21 May 2018

21 May 2018

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 17 May 2018 Mr Rick Anderson, a Non-Executive Director and a PDMR, acquired 1,116 Shares at GBP2.03 per share under the Company's Scrip Dividend programme. Mr Anderson's resulting shareholding is 74,050 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                              Mr Rick Anderson 
----  ------------------------------------------------  -------------------------------------------------------------- 
  2     Reason for the notification 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Position/Status                                   Non-Executive Director 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    Initial notification/Amendment                    Initial Notification 
----  ------------------------------------------------  -------------------------------------------------------------- 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Name                                              ConvaTec Group Plc 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    LEI                                               213800LS272L4FIDOH92 
----  ------------------------------------------------  -------------------------------------------------------------- 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
----  ---------------------------------------------------------------------------------------------------------------- 
  a)    Description of the financial                      Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") 
         instrument, type of instrument                    GB00BD3VFW73 
         Identification code 
----  ------------------------------------------------  -------------------------------------------------------------- 
  b)    Nature of the transaction                         Acquisition of Shares via Scrip Dividend Scheme 
----  ------------------------------------------------  -------------------------------------------------------------- 
  c)    Price(s) and volume(s)                            Price(s)                                         Volume(s) 
                                                           GBP2.03                                          1,116 
----  ------------------------------------------------  -----------------------------------------------  ------------- 
  d)    Aggregated information 
         - Aggregated volume                                1,116 
         - Price                                            GBP2,261.02 
----  ------------------------------------------------  -------------------------------------------------------------- 
  e)    Date of the transaction                           17 May 2018 
----  ------------------------------------------------  -------------------------------------------------------------- 
  f)    Place of the transaction                          London Stock Exchange, Main Market (XLON) 
----  ------------------------------------------------  -------------------------------------------------------------- 
 
 

Enquiries

Media

   Bobby Leach, VP Group Corporate Affairs, ConvaTec                        +44 (0)7770 842 226 

Alastair Elwen, Finsbury +44 (0)207 251 3801

Analysts and Investors

   John Crosse, VP Investor Relations, ConvaTec                         +44 (0)7500 141 435 
   Kirsty Law, Director Investor Relations, ConvaTec                               +44 (0)7470 909 582 

investorrelations@convatec.com

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLLFELEDILFIT

(END) Dow Jones Newswires

May 21, 2018 08:02 ET (12:02 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock